Glargine Insulin Is Not an Alternative in Insulin Allergy
2003; American Diabetes Association; Volume: 26; Issue: 7 Linguagem: Inglês
10.2337/diacare.26.7.2216
ISSN1935-5548
AutoresKarine-Noelle Durand-Gonzalez, Nicolas Guillausseau, Catherine Pecquet, Jean-Pierre Gayno,
Tópico(s)Drug-Induced Adverse Reactions
ResumoAllergy to insulin is rare with human recombinant insulin and is now reported for <1% of diabetic patients. Clinic symptoms are usually local and appear a few minutes after the injection (red blotch, induration, pruritus, and burning sensation at insulin injection sites) and are rarely general (from urticaria to anaphylactic shock). A decrease of the efficiency of the insulin is usually associated with these symptoms. Different methods have been proposed for the treatment of insulin allergy including the use of oral antihistaminics, the addition …
Referência(s)